Experts Call for Women's Heart Centers to Tackle Inequality in Diagnosis and Care

Why It Matters

Women’s cardiovascular disease is underdiagnosed and undertreated, driving higher mortality; dedicated centers promise faster, more accurate care and a platform for gender‑focused research, reshaping outcomes across Europe.

Key Takeaways

• Women die from heart disease at higher rates due to diagnostic delays.
• European consensus recommends dedicated women's heart centers within existing hospitals.
• Canadian center diagnosed over 70% of previously unexplained female cardiac cases.
• Centers will provide advanced imaging, research coordination, and clinician education.
• Ongoing audits required to prove impact and secure funding.

Pulse Analysis

Cardiovascular disease remains the leading cause of death for women, yet they are twice as likely as men to experience diagnostic delays and receive sub‑optimal treatment. Unique risk factors—such as pregnancy‑related complications, early menopause and autoimmune conditions—are often omitted from standard risk models, contributing to a mortality gap where three in ten women worldwide succumb to heart disease. This disparity has spurred a growing call for gender‑specific care pathways that recognize the distinct presentation of cardiac symptoms in women.

In response, a coalition of European experts authored a consensus statement urging the creation of women’s heart centers embedded within existing cardiovascular facilities. Drawing on data from North American hubs, the report notes that a Canadian center achieved a 70% diagnostic success rate for previously unexplained female cardiac complaints, reducing hospital admissions over three years. The proposed centers would serve as multidisciplinary hubs, offering advanced imaging, specialist consultations, research coordination, and targeted education for clinicians. By centralizing expertise, they aim to accelerate diagnosis, tailor treatment plans, and generate robust data on women‑focused outcomes.

For Europe, the recommendation aligns with the EU’s public‑health priority on women’s cardiovascular health and offers a scalable model adaptable to diverse health‑system structures. Continuous auditing will quantify clinical impact, justify funding, and inform policy. Moreover, integrating women‑specific curricula into cardiology training will elevate baseline competence across the workforce. As these centers proliferate, they are poised to narrow the gender gap, foster innovative research, and ultimately improve survival and quality of life for millions of women across the continent.